Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial
Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page
- Check2 days agoChange DetectedEnrollment status updated to indicate recruitment has ended. The page adds new help sections and slightly updates header text and version labeling.SummaryDifference0.2%

- Check9 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This change reflects an updated record version rather than changes to study content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a newer build of the page. The previous Revision: v3.5.3 tag has been removed.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page content adds references in the footer area (including a “resources” section for related topics) and updates the site revision/version label. The previous revision label (v3.5.2) was replaced with the newer one (v3.5.3).SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.0%

- Check81 days agoChange DetectedRemoved the Interstitial lung disease 2 item and the Genetic and Rare Diseases Information Center resources from the page.SummaryDifference0.1%

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.